AGP Picks
View all

Health Wire Cabo Verde
Provided by AGP

Health Wire Cabo Verde: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Cabo Verde.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 8, 2026

AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance
May 8, 2026

AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance

Indeterminate GlobeNewswire
ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology
May 8, 2026

ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology

Indeterminate GlobeNewswire
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
May 8, 2026

Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma

Indeterminate GlobeNewswire
Philips shareholders approve all proposals at the AGM 2026
May 8, 2026

Philips shareholders approve all proposals at the AGM 2026

Indeterminate GlobeNewswire
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
May 8, 2026

Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma

Indeterminate GlobeNewswire
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
May 8, 2026

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Indeterminate GlobeNewswire
AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds
May 8, 2026

AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds

Indeterminate GlobeNewswire
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
May 8, 2026

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

Indeterminate GlobeNewswire
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026

CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
May 8, 2026

InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares

Indeterminate GlobeNewswire
MIMEDX Announces Launch of G4Derm® Plus
May 8, 2026

MIMEDX Announces Launch of G4Derm® Plus

Indeterminate GlobeNewswire
Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026
May 8, 2026

Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026

Indeterminate GlobeNewswire
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026

Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
May 8, 2026

OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)

Indeterminate GlobeNewswire
Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données
May 8, 2026

Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données

Indeterminate GlobeNewswire
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
May 8, 2026

LENSAR® Reports First Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire
Hyperion DeFi Announces Closing of Public Offering of Common Stock
May 8, 2026

Hyperion DeFi Announces Closing of Public Offering of Common Stock

Indeterminate GlobeNewswire
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
May 8, 2026

Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
May 8, 2026

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Wire Cabo Verde

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.